|
"whang peng j"的相關文件
顯示項目 176-200 / 215 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2002-07 |
Palliative meflep therapy in advanced pancreatic cancer: Excellent response in a patient with her-2/neu amplification
|
Chao, Y;Liu, JM;YauLi, AF;Perng, CL;Tiu, CM;King, KL;Chen, LT;Lin, WC;Lan, C;Whang-Peng, J |
| 國家衛生研究院 |
2002-05 |
Phase II and pharmacokinetic study of GL331 in previously treated Chinese gastric cancer patients
|
Liu, JM; Chen, LT; Chao, Y; Li, AFY; Wu, CW; Liu, TS; Shiah, HS; Chang, JY; Chen, CT; Wu, HW; Lin, WC; Lan, C; Whang-Peng, J |
| 國家衛生研究院 |
2002-02 |
Additive effect of interleukin-12 and interleukin-18 on the T-helper cell pathway of malignant pleural effusion
|
Yao, NS; Chen, YM; Perng, RP; Whang-Peng, J |
| 國家衛生研究院 |
2002-01 |
Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated
|
Chen, YM; Perng, RP; Lee, YC; Shih, JF; Lee, CS; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2002 |
A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer
|
Chen, LT; Liu, TW; Wu, CW; Chung, TR; Shiah, HS; Jan, CM; Liu, JM; Whang-Peng, J; Chang, JY |
| 國家衛生研究院 |
2002 |
Phase I and pharmacokinetic studies of oral thalidomide in advanced hepatocellular carcinoma
|
Chen, LT;Chao, Y;Yao, TJ;Huang, JD;Chang, JY;Chin, YH;Chuang, TR;Reed, E;Whang-Peng, J;Liu, TW |
| 國家衛生研究院 |
2001-10 |
Efficacy of Re-188-labelled sulphur colloid on prolongation of survival time in melanoma-bearing animals
|
Chen, FD; Hsieh, BT; Wang, HE; Ou, YH; Yang, WK; Whang-Peng, J; Liu, RS; Knapp, FF; Ting, G; Yen, SH |
| 國家衛生研究院 |
2001-09-01 |
Inverted repeats as genetic elements for promoting DNA inverted duplication: implications in gene amplification
|
Lin, CT; Lin, WH; Lyu, YL; Whang-Peng, J |
| 國家衛生研究院 |
2001-08-15 |
Suppression of gene amplification and chromosomal DNA integration by the DNA mismatch repair system
|
Lin, CT; Lyu, YL; Xia, H; Lin, WH; Whang-Peng, J |
| 中國醫藥大學 |
2001-04-05 |
Differential effects of antigen loading and coordinated activation of dendritic cells by different forms of tumor cells expressing CD40 ligand.
|
(Liu, K.-J.)*; 莊聲宏(Shin-Hun Juang); (Wang, C.-C.); (Ting C.-C.); (Whang-Peng, J.) |
| 國家衛生研究院 |
2001-04 |
Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: Comparison of malignant and tuberculous pleural effusions
|
Chen, YM; Tsai, CM; Whang-Peng, J; Perng, RP |
| 國家衛生研究院 |
2001-01 |
An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer
|
Chen, YM; Yang, WK; Whang-Peng, J; Tsai, CM; Perng, RP |
| 國家衛生研究院 |
2000-12 |
Phase II study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer
|
Chen, YM; Perng, RP; Whang-Peng, J; Wu, HW; Lin, WC; Tsai, CM |
| 國家衛生研究院 |
2000-08 |
Phase II study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000-06 |
A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Liu, TW; Tsai, CM; Liu, JM; Whang-Peng, J |
| 國家衛生研究院 |
2000-05-25 |
PIK3CA as an oncogene in cervical cancer
|
Ma, YY; Wei, SJ; Lin, YC; Lung, JC; Chang, TC; Whang-Peng, J; Liu, JM; Yang, DM; Yang, WK; Shen, CY |
| 國家衛生研究院 |
2000-05 |
Development of DNA delivery system using Pseudomonas exotoxin A and a DNA binding region of human DNA topoisomerase I
|
Chen, TY; Hsu, CT; Chang, KH; Ting, CY; Whang-Peng, J; Hui, CF; Hwang, J |
| 國家衛生研究院 |
2000-05 |
Integration of computer-assembled digital images and text data as evidence for the oncological record
|
Liu, JM; Wu, HW; Chen, WS; Lin, WC; Chao, Y; Lui, WY; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents
|
Huang, TS; Shu, CH; Lee, CC; Chen, LT; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer
|
Perng, RP; Shih, JF; Chen, YM; Delgado, FM; Tsai, CM; Chou, KC; Liu, JM; Chern, MS; Whang-Peng, J |
| 國家衛生研究院 |
2000-02 |
A phase II trial of tamoxifen, ifosfamide, epirubicin, and cisplatin combination chemotherapy for inoperable non-small-cell lung cancer
|
Chen, YM; Perng, RP; Yang, KY; Lin, WC; Wu, HW; Liu, JM; Tsai, CM; Whang-Peng, J |
| 國家衛生研究院 |
2000 |
Phase II study of docetaxel plus gemcitabine in patients with non-small cell lung cancer (NSCLC) that failed previous chemotherapy (CT)
|
Chen, YM;Perng, RP;Whang-Peng, J;Lin, WC;Wu, HW;Tsai, CM |
| 國家衛生研究院 |
1999-12 |
Depressed cytolytic activity of peripheral blood mononuclear cells in unusually high paclitaxel concentrations: Reversal by IL-2 and IL-12
|
Chen, Y;Yang, W;Ting, C;Yang, D;Whang-Peng, J;Perng, R |
| 國家衛生研究院 |
1999-11 |
The significance of body weight change in non-Hodgkins lymphoma
|
Chin, YH; Liu, JM; Tai, JJ; Chuang, MS; Ho, YL; Chen, YM; Whang-Peng, J; Cheng, AL |
| 國家衛生研究院 |
1999-09 |
Analysis of astrocytoma heterogeneity: Detection of telomere shortening, BCL-2 expression, and multiple gains and losses of genetIc material in four primary cultures of astrocytoma
|
Chen, MH;Lee, CC;Chin, CC;Whang-Peng, J;Huang, TS |
顯示項目 176-200 / 215 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
|
